This work represents a collaboration between members of the infectious diseases department and the pharmacy department of CHU Ste-Justine with the participation of colleagues in emergency medicine and the general pediatrics department.

ApP (Pediatric Antibiotherapy) attempts to provide a rapid response to prescribers' questions regarding the choice of anti-infectives and their dosage, in a given pediatric population. The therapeutic choices recommended in this ApP come above all from the experience acquired at CHU Sainte Justine over the 22 years of existence of the infectious diseases department. They reflect our choices of daily treatment strategies based on our experience and local epidemiology. They are not necessarily copied and may differ from various recommendations of learned societies or government agencies.

The content is presented in three main sections:
● Topics - General information on infectious diseases
● Medications – Dosages, main interactions… everything you need.
● Pathogens – Learn about pathogens; bacteria, viruses, parasites, protozoa…

Biannual updates are planned.

This app is not affiliated with CHU Sainte-Justine or any government entity. The dosages are inspired by hospital clinical practices, particularly those observed at CHU Sainte-Justine.

Main authors
- Marc H. Lebel MD, Department of Infectious Diseases
- Hélène Roy BPharm, Department of Pharmacy
- Philippe Ovetchkine MD, Department of Infectious Diseases

ABOUT THE SUBSCRIPTION
Pediatric Antibiotic Therapy distributed in the form of an annual subscription, automatically renewable.

Subscription fees will be charged to your iTunes account when you confirm your purchase.

The subscription will automatically renew unless you turn off the auto-renew feature at least 24 hours before the end of the current subscription period.

You can change the terms of your subscription by going to the “Manage Subscription” section of Google Play.

For more information on the terms of use visit https://pdr.publicatique.com/fr/terms-of-use

Messil inc.

Latest release